Clinical Trial Update: Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

View source ↗

Summary

Completed study by NIAID investigates proteogenomic biomarker panels in serial blood and urine monitoring of kidney transplant recipients to improve post-transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplant, Kidney Transplantation | Status: COMPLETED